Research

Cellular

Tirzepatide treatment significantly decreased Alt-Ext-induced IL-5 and IL-13 levels in lung homogenates compared with vehicle treatment.

Tirzepatide may help reduce allergic inflammation in obese asthma patients.

StrongSupportsmedium confidence
Alt-Ext-induced IL-5 and IL-13 were significantly decreased in the tirzepatide treatment group compared with the vehicle treatment group.
Shinji Toki et al. · Clinical & Experimental Allergy · 2022

Why this rating

Based on direct measurement of inflammatory markers.

Source

Dual GIPR and GLP‐1R agonist tirzepatide inhibits aeroallergen‐induced allergic airway inflammation in mouse model of obese asthma

Shinji Toki et al. · Clinical & Experimental Allergy · 2022

DOI 10.1111/cea.14252

otherCited 16×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →